Brendel, Matthias http://orcid.org/0000-0002-9247-2843
Deussing, Maximilian
Blume, Tanja
Kaiser, Lena
Probst, Federico
Overhoff, Felix
Peters, Finn
von Ungern-Sternberg, Barbara
Ryazanov, Sergey
Leonov, Andrei
Griesinger, Christian
Zwergal, Andreas
Levin, Johannes
Bartenstein, Peter
Yakushev, Igor
Cumming, Paul
Boening, Guido
Ziegler, Sibylle
Herms, Jochen
Giese, Armin
Rominger, Axel
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (Synergy Cluster for Systems Neurology)
FP7 Ideas: European Research Council (603002)
Article History
Received: 28 March 2019
Accepted: 22 July 2019
First Online: 1 August 2019
Ethics approval and consent to participate
: All experiments were carried out in compliance with the National Guidelines for Animal Protection, Germany, with the approval of the regional Animal Care Committee of the Government of Oberbayern (Regierung Oberbayern) and were overseen by a veterinarian. Animal experiments were conducted in accordance with the guidelines EU Directive 2010/63/EU and ARRIVE for animal experiments.
: Not applicable.
: SR, AL, AG, and CG are inventors in a patent application related to the compound use in this study. AG and CG are co-founders of MODAG. AL is partly employed by MODAG. All other authors declare that they have no competing interests.